Drug for rare form of Lou Gehrigs disease OKd by FDA

WASHINGTON (AP) — Food and Drug Administration regulators on Tuesday approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease, though they are requiring further research to confirm it truly helps patients. The FDA approved Biogen’s injectable drug for patients with a rare genetic mutation that’s estimated to…Read More